Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from ELEVAI Labs Inc. (ELAB).
Elevai Labs Inc. faces a challenge as it has fallen below Nasdaq’s minimum bid price requirement, prompting a notice from Nasdaq that could lead to delisting if not rectified. The company has 180 days to boost its stock price above $1 for at least 10 consecutive days to maintain its listing. Meanwhile, the board undergoes changes with Crystal Muilenburg stepping down and George Kovalyov stepping in, receiving an incentive package including stock options for his new role as chairman of the Compensation Committee.
For detailed information about ELAB stock, go to TipRanks’ Stock Analysis page.